CD8+TEMRA clinical trials

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

This study looks for a special marker in your blood called CD8+TEMRA cells, which might predict how well your broken bone will heal. It aims to help doctors know early on if someone might need extra help for their bone to mend properly, preventing longer recovery times.